Home » Topics » BioWorld Science

BioWorld Science
RSS

resTORbio stops development of RTB-101 for clinically symptomatic respiratory illness

Nov. 15, 2019

Interim data presented from phase I study of TK-216 in Ewing's sarcoma

Nov. 15, 2019

FDA grants accelerated approval to Brukinsa for mantle cell lymphoma

Nov. 15, 2019

FDA approves Fetroja for complicated urinary tract infections

Nov. 15, 2019

I-Mab obtains Chinese IND clearance for phase I trials of TJM-2 in rheumatoid arthritis

Nov. 15, 2019

Phase II study of AV-101 in major depressive disorder does not meet primary endpoint

Nov. 15, 2019

Results from SILK cohort evaluating tesevatinib in ADPKD patients presented at Kidney Week

Nov. 15, 2019

New IDO-1 inhibitors identified at Phenex Discovery Verwaltungs

Nov. 15, 2019

Pfizer patents cyclin-dependent kinase inhibitors

Nov. 15, 2019

New mu-opioid receptor agonists identified at Sichuan Kelun-Biotech Biopharmaceutical

Nov. 15, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...